Apyx Other Thursday, May 21, 2026 +0.75 Positive

Apyx Medical publishes clinical data showing cellulite treatment efficacy

Apyx Medical announced publication of clinical study results demonstrating up to 81.8% improvement in cellulite appearance using combined Avéli and Renuvion treatments. The positive data supports the company's surgical aesthetics product portfolio addressing a market affecting up to 90% of post-pubertal women.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day